Our trustees provide strategic guidance and direction, ensuring that goals are in place to drive forward our support of research, treatment and welfare of children suffering with cancer.
David has spent the last 30 years in the City of London as an Investment Banker. He sold his own business in 2016 and now works in Real Estate and Private Equity. David has other business interests in television and music. He has been married for 20 years and has three teenage children.
Alex Leitch has practised as a professional litigation lawyer in the City of London for over 30 years. Formerly a practising barrister, he was one of the UK’s first and youngest solicitors to become a solicitor-advocate. He is currently a partner in a Top 10 Global Law Firm where he is the UK Head of Complex Disputes. He acts for clients across many sectors including financial services, life sciences and healthcare and private equity. Throughout his career he has been an active supporter and sponsor of several children’s charities. He is married and has a teenage son.
Phil Hall is a former national newspaper editor and editor in chief of a global magazine. Phil Hall went on to be the founder of one of the top independent PR agencies in the UK, The PHA Group in 2005. Renowned for his contacts in senior media roles and in the sporting world and business. He specialises in reputation management of businesses and individuals and represents high profile individuals from Government, industry and the sport and entertainment world. He has been recognised as an industry leader by Spears, PR Week and Chambers and Partners.
Bruce Morland recently retired as a Professor of Paediatric Oncology at Birmingham Women’s and Children’s Hospital. He spent his career managing children with non-CNS (Central Nervous System) solid tumours and is an international expert in the treatment of liver and bone tumours. He has extensive experience in the development of novel new therapies for childhood cancer and the conduct of early phase clinical trials. He was previously Chairman of the Children’s Cancer and Leukaemia Group (CCLG).
Pamela Kearns is Professor of Clinical Paediatric Oncology at the University of Birmingham and an Honorary Consultant Paediatric Oncologist at Birmingham Women and Children’s Hospital. She is Director of the University of Birmingham’s Institute of Cancer and Genomic Sciences and Director of the Cancer Research UK Clinical Trials Unit (CRCTU). She is a Trustee for Cancer Research UK as well as A Child of Mine, a charity dedicated to supporting bereaved parents. She is also Chair of the Research Assessment Panel for GOSH Charity, and Chair of The Independent Scientific Advisory Panel for Bone Cancer Research Trust.